Association of plasma LACTATE (cas 113-21-3) concentration at admission of severe preeclampsia to maternal complications
-
Add time:08/21/2019 Source:sciencedirect.com
ObjectiveTo evaluate in women with severe preeclampsia the association of LACTATE (cas 113-21-3) concentration at admission with maternal complications.
We also recommend Trading Suppliers and Manufacturers of LACTATE (cas 113-21-3). Pls Click Website Link as below: cas 113-21-3 suppliers
Prev:Cardiovascular pharmacologyPharmacological evidence that 5-HT1A/1B/1D, α2-adrenoceptors and D2-like receptors mediate ergotamine (cas 113-15-5)-induced inhibition of the vasopressor sympathetic outflow in pithed rats
Next:Original ContributionsDoes Intravenous LACTATE (cas 113-21-3)d Ringer’s Solution Raise Serum LACTATE (cas 113-21-3)?) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Heart-rate-based prediction of velocity at LACTATE (cas 113-21-3) threshold in ordinary adults08/30/2019
- Fiber optic surface plasmon resonance based LACTATE (cas 113-21-3) sensor using co-immobilization of LACTATE (cas 113-21-3) dehydrogenase and NAD+08/29/2019
- LACTATE (cas 113-21-3)-Mediated Protection of Retinal Ganglion Cells08/28/2019
- The NIR inspired nano-CuSMn(II) composites for LACTATE (cas 113-21-3) and glycolysis attenuation08/27/2019
- ArticleLACTATE (cas 113-21-3) Is a Natural Suppressor of RLR Signaling by Targeting MAVS08/26/2019
- An ultrasensitive amperometric determination of LACTATE (cas 113-21-3) by LACTATE (cas 113-21-3) dehydrogenase nanoparticles immobilized onto Au electrode08/25/2019
- LACTATE (cas 113-21-3)-stimulated ethanol oxidation: Revisiting an old hypothesis08/24/2019
- Synthesis of LACTATE (cas 113-21-3) derivatives via reductive radical addition to α-oxyacrylates08/23/2019
- Original ContributionsDoes Intravenous LACTATE (cas 113-21-3)d Ringer’s Solution Raise Serum LACTATE (cas 113-21-3)?08/22/2019
